Corticosteroids in the management of prostate cancer: a critical review

Current Treatment Options in Oncology
Chukwuma NdibeGuru Sonpavde

Abstract

Corticosteroids have been used in the management of prostate cancer for over 30 years. Although daily oral corticosteroids have frequently used in conjunction with chemotherapy for metastatic castration-resistant prostate cancer, their independent impact on survival is unclear. However, corticosteroids confer palliative benefits and are associated with objective responses and circulating tumor cell (CTC) and PSA declines in a small minority of patients, although toxicities such as osteoporosis and immunosuppression complicate long-term use. Following the demonstration of a palliative benefit for mitoxantrone combined with corticosteroids compared with corticosteroids alone, subsequent trials that demonstrated a benefit for first-line docetaxel over mitoxantrone, and second-line cabazitaxel over mitoxantrone, administered concurrent daily oral corticosteroids with all of these agents to maintain uniformity. Conversely, improved outcomes were demonstrated with docetaxel without corticosteroids for metastatic castration-sensitive prostate cancer. Daily oral corticosteroids are routinely combined with abiraterone to mitigate symptoms of mineralocorticoid excess. In contrast daily corticosteroids are not essential when administering...Continue Reading

References

May 1, 1989·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I TannockW Rider
May 25, 1995·The New England Journal of Medicine·M E TaplinS P Balk
Jun 1, 1996·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·I F TannockK C Murphy
Nov 24, 1999·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·P W KantoffN J Vogelzang
Jun 8, 2001·International Journal of Urology : Official Journal of the Japanese Urological Association·T SaikaUNKNOWN Okayama Urological Cancer Collaborating Group
Nov 8, 2001·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T M BeerW D Henner
Nov 22, 2001·Journal of the National Cancer Institute·K NishimuraA Okuyama
Jul 16, 2003·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Mary-Ellen TaplinUNKNOWN Cancer and Leukemia Group B Study 9663
Oct 8, 2004·The New England Journal of Medicine·Ian F TannockUNKNOWN TAX 327 Investigators
Oct 8, 2004·The New England Journal of Medicine·Daniel P PetrylakE David Crawford
May 19, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akihiro YanoKazunori Kihara
Sep 20, 2006·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Nancy L KeatingMatthew R Smith
Oct 26, 2006·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Akihiro YanoKazunori Kihara
Jul 28, 2007·Cancer·Christopher S SaigalUNKNOWN Urologic Diseases in America Project
Jun 7, 2008·Jornal de pediatria·Crésio AlvesMilena Mendonça
Sep 2, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Gerhardt AttardJohann S de Bono
Sep 8, 2010·The New England Journal of Medicine·Philip W KantoffUNKNOWN IMPACT Study Investigators
Apr 13, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Howard I ScherGlenn Heller
May 27, 2011·The New England Journal of Medicine·Johann S de BonoUNKNOWN COU-AA-301 Investigators
Dec 8, 2011·JAMA : the Journal of the American Medical Association·Paul L NguyenToni K Choueiri
Jul 27, 2012·Annals of Oncology : Official Journal of the European Society for Medical Oncology·T B Dorff, E D Crawford
Aug 17, 2012·The New England Journal of Medicine·Howard I ScherUNKNOWN AFFIRM Investigators
Dec 12, 2012·The New England Journal of Medicine·Charles J RyanUNKNOWN COU-AA-302 Investigators
Jul 3, 2013·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Charles J RyanHoward I Scher
Jul 19, 2013·The New England Journal of Medicine·C ParkerUNKNOWN ALSYMPCA Investigators
Mar 7, 2014·The New England Journal of Medicine·Nima Sharifi
Jun 3, 2014·The New England Journal of Medicine·Tomasz M BeerUNKNOWN PREVAIL Investigators
May 1, 2015·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Eric J SmallNeal D Shore

❮ Previous
Next ❯

Citations

Feb 10, 2016·Prostate Cancer and Prostatic Diseases·B A TeplyE S Antonarakis
Apr 14, 2016·Trends in Pharmacological Sciences·Jan KroonGabri van der Pluijm
May 11, 2016·European Journal of Cancer : Official Journal for European Organization for Research and Treatment of Cancer (EORTC) [and] European Association for Cancer Research (EACR)·Giandomenico RovielloDaniele Generali
Nov 23, 2016·Nature Reviews. Clinical Oncology·Guilhem RoubaudDavid J Mulholland
Nov 24, 2016·Der Urologe. Ausg. A·H Kübler
Aug 16, 2017·Endocrine-related Cancer·Roberta Visconti, Domenico Grieco
Feb 10, 2019·British Journal of Clinical Pharmacology·Bodine P S BelderbosRon H J Mathijssen
Oct 7, 2019·Drug Safety : an International Journal of Medical Toxicology and Drug Experience·Neil M SchultzBenjamin Lowentritt
Mar 24, 2020·Nature Reviews. Urology·Marc Carceles-CordonJosep Domingo-Domenech
Nov 22, 2017·Clinical Cancer Research : an Official Journal of the American Association for Cancer Research·Martin PuhrHelmut Klocker
Mar 20, 2020·Biomacromolecules·Philip Maximilian KnaffVolker Mailänder

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.